Therefore, given its critical relevance in metabolic disorders, we conducted an unprecedented investigation into the serum levels of NOV among CAD patients, as well as its correlation with TNF-α, IL-6, and various biochemical parameters. This evidence concerns the gene TNF and coronary artery disorder.